FDA Adverse Event Death Summary report: N

INFUSE BONE GRAFT

MDR report key: 2071042 · Received April 27, 2011

Report

Report Number
1030489-2011-00459
Event Type
Death
Date Received
April 27, 2011
Report Date
March 29, 2011
Manufacturer
MEDTRONIC SOFAMOR DANEK
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE AVERAGE AGE OF THE STUDY PATIENTS WAS (B)(6) YEARS. THE AGE OF THIS PATIENT IS UNKNOWN. THE STUDY CONSISTED OF 468 MALES AND 690 FEMALES. THE GENDER OF THIS PATIENT IS UNKNOWN. THE DATE OF DEATH IS AN ESTIMATED DATE; THE ACTUAL DATE OF DEATH IS UNKNOWN. THE DATE PROVIDED WAS FOR EMDR TRANSMISSION PURPOSES. BONE VOID FILLER (DETAILS NOT PROVIDED) POSTERIOR INSTRUMENTATION (DETAILS NOT PROVIDED). (B)(4). A REVIEW OF THE CERTIFICATES OF ANALYSIS AND PACKING LIST FOR THE INFUSE BONE GRAFT WAS NOT POSSIBLE WITHOUT ADDITIONAL DEVICE INFORMATION. NEITHER THE DEVICE NOR APPLICABLE IMAGING FILMS WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. ALTHOUGH IT IS UNKNOWN IF THE DEVICE CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

POST OPERATIVE COMPLICATIONS WERE REPORTED IN A RETROSPECTIVE STUDY OF PATIENTS WHO UNDERWENT INSTRUMENTED LUMBAR POSTEROLATERAL FUSION WITH RHBMP-2 AT A SINGLE PRACTICE BY FIVE ORTHOPEDIC SURGEONS BETWEEN (B)(6) 2002 AND (B)(6) 2009. PERSISTENT SYMPTOMS REFRACTORY TO NON-OPERATIVE TREATMENT INCLUDED NONSTEROIDALS, PHYSICAL THERAPY AND/OR SPINAL INJECTIONS EXISTED. THE MEAN TOTAL BMP-2 DOSE WAS 12.5 MG PER PATIENT (RANGE 4.2-36.0). PATIENT FOLLOW-UP OCCURRED AT TWO WEEKS, SIX WEEKS, TWELVE WEEKS, SIX MONTHS, ONE YEAR AND LATER IF REQUIRED. IT WAS REPORTED THAT THE PATIENT DIED DURING HOSPITALIZATION AS A RESULT OF PULMONARY EMBOLISM. NO FURTHER DETAILS WERE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK NA NA

Patients

Seq Age Sex Outcome Treatment
1 00059 YR Death